Skip to content

DR. STALS

Active
Private limited companyfounded 1999active for 27 yearsStationsstraat 3, 3665 As, BelgiumKBO/BCE: BE 0466.507.939
Summary

DR. STALS has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €1.2m and a net result of €188,201. Equity is growing by about 11% per year across the filed financial years. Its solvency ranks better than 45% of 274 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR. STALSActiveChecked score 93/100
Risk analysis ReportCompare

Overview

Activity
Medical imaging and medical laboratories
NACE 86910
3rd largest company by total assets in As, Health and social work sector1 site
Size
€1.7mtotal assets 2026
Equity
€1.2m
Profit
€188,201
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2026 accounts 37 days early1 of 3 deeds summarised
Why 93lowers riskSector: Human health activities (NACE 86)Size: total assets €1.7mFigures for financial year 2026 (filed 24-09-2026)Equity €1.2m (67.9% of total assets)Show the evidence

Checked score

Score 2026
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 45% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2025
Strong
Solvency 93+3
equity 67.9% of total assets
Liquidity 56-30
short-term debt 30.0% · cash 14.5%
Profitability 83-2
return on assets 11.1%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,112 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €100,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.05, compared with 2.79 in 2025, above the usual 1.5; short-term debt: 30% and cash: 14.5% of total assets), and 32.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 56% on solvency, 31% on liquidity, 31% on profitability and 64% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €1.7m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2026 (filed 24-09-2026)
NBB · annual accounts
lowers risk · Equity €1.2m (67.9% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 24-09-2026, 37 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
37 days early
2025
43 days early
2024
23 days early
2023
49 days late
2022
5 days early
2021
32 days early
2020
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 15 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 8 October (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · micro…
  2. Equity above €1mequity €1.2m ▲19.4%
  3. Annual accounts filedfinancial year 2025 · micro…

Key points

  • Positive: 3rd largest company by total assets in As, Health and social work…in the Checked rankings No. 3 View
  • Positive: 8 profitable years in a rowprofit 2026: €188,201 8 years View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2026
Total assets
€1.7m
Profit
€188,201
Solvency
67.9%
Total assets▲ 14.5%
Net result
20192026
Go to Financials

Timeline

Events
31
Since
2002
Next accounts
by 31-10-2027
  1. 31-03-2025Highest result from 2019 to 2026
  2. 08-10-2024Annual accounts filed
  3. 12-01-2024Resignation: STALS Theo Mathieu Philip Carolus (director)
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Medical imaging and medical laboratoriesNACE 86910
Founded
09-07-1999
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
14
Who signs
Each director alone
Purpose
“De uitoefening van de algemene geneeskunde door de geneesheer-aandeelhouder of…” (deed in Dutch)
Go to Articles of association

Key facts about DR. STALS

What is the company number of DR. STALS?
0466.507.939. In Belgium the VAT number is the company number with BE in front: BE 0466.507.939.
Where is DR. STALS based?
The registered office is at Stationsstraat 3, 3665 As.Company details
What does DR. STALS do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of DR. STALS?
Private limited company (BV).
When was DR. STALS founded?
On 09-07-1999.
Is DR. STALS still active?
Yes, DR. STALS is an active enterprise in the KBO register.
What is the turnover of DR. STALS?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR. STALS profitable?
In financial year 2026, DR. STALS made a profit of €188,201.
Where can I find the annual accounts of DR. STALS?
DR. STALS filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of DR. STALS due?
By 31-10-2027, for financial year 2027.Timeline

Companies related to DR. STALS

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure